Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.

This study tested a new medicine called TQC2731, given as an injection, for people with long-term sinus inflammation and nasal polyps (growths in the nose). The goal was to see if it is safe and helps control symptoms. The trial involved 59 adults who had already taken part in an…

This study tested a new oral medication called TQH3906 in 209 adults with moderate to severe plaque psoriasis. The goal was to see if it can safely clear skin patches and reduce symptoms like scaling and itching. Researchers measured how many patients achieved at least a 75% impr…

This study tested an investigational injection called TQC2938 in 136 adults with seasonal allergic rhinitis (hay fever). All participants also used a standard nasal spray. The goal was to see if the injection could further reduce daily nasal symptoms like sneezing and congestion …